View all results
No results
News
Events
The industry
Industry overview
Industrial biotech
Swiss Biotech Report
Success stories
Company directory
Jobs
Talent platform
Networking platforms
Newsletter
Association
Mission & services
Members
Academy
Insight Events
Partners
Team
Media
Add listing
Log in
or
Register
0
Add listing
TOTIPHARMACEUTICAL
TOTIPHARMACEUTICAL
Product
prev
next
Leave a review
Claim listing
Bookmark
Share
Report
prev
next
Indicaton
Polypharmacology for all therapeutic aeras using nano-drug delivery systems
Therapeutic indications
Autoimmmune diseaese
Cardiovascular
CNS
Dermatology
Infectious disease
Inflammation
Metabolic disorder
Mitochondrial disease
Neurology
Neuromuscular
Oncology
Ophthalmology
Pain
Respiratory
Women’s health
Type of product
Small molecule
Table
Phase
Discovery
Available in
EU
You may also be interested in
Proclarix
Proclarix® is CE marked, intended for in vitro diagnostic use and indicated for prostate cancer diagnosis in patients with normal digital rectal exam (DRE), enlarged prostate volume and elevated levels of PSA at 2-10 ng/ml.
Featured
Marketed
Dimiracetam
Management of acute and chronic symptoms of chemotherapy-induced sensory peripheral neuropathy.
Featured
Phase II started
Dicholine succinate (DISU) nasal spray
chronic rhinosinusitis (CRS)
Featured
Phase II completed
Cart
×
View all results
No results
X
WhatsApp
LinkedIn
Mail
Copy link
Share via...
Bluesky
This site uses cookies:
Find out more.
Accept